1-3 of 3
Seval Türkmen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Anne Flörcken, MD, Schneider Tanja, MD, Anju Singh, MD, Seval Türkmen, MD, Burmeister Thomas, MD PhD, Joannis Anagnostopoulos, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Jörg Westermann, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1006.
https://doi.org/10.1182/blood.V124.21.1006.1006
Published: 2014
Journal Articles

Differential Expression of SHP-1 Levels in Chronic Phase and Advanced Disease CML and in AML Patients

Jaspal S Kaeda, PhD, Christian Oberender, Daniel Neuman, Theo Kim, MD, Ken I Mills, PhD, Anna Serra, PhD, Philipp Hemmati, MD, Regina Schleede, Tim Overkamp, Frauke Ringel, PhD, Thomas Pretzsch, Seval Turkmen, MD, Michaela Schwarz, MD, Renate Arnold, MD, Bernd Dörken, MD, Philipp le Coutre, MD
Journal: Blood
Blood (2012) 120 (21): 1449.
https://doi.org/10.1182/blood.V120.21.1449.1449
Published: 2012
Journal Articles

Bcr-Abl and Wilms Tumor Gene (WT1) Kinetics in Nilotinib (AMN107) Treated CML Patients.

Michaela Schwarz, MD, Gokben Baskaynak, MD, Seval Turkmen, MD, Peter Schuld, MD, Bernd Dorken, MD, Peter Daniel, MD, le Coutre Philipp
Journal: Blood
Blood (2006) 108 (11): 2336.
https://doi.org/10.1182/blood.V108.11.2336.2336
Published: 2006